Price T Rowe Associates Inc Landec Corp \Ca\ Transaction History
Price T Rowe Associates Inc
- $812 Billion
- Q1 2025
A detailed history of Price T Rowe Associates Inc transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Price T Rowe Associates Inc holds 10,799 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,799Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LNDC
# of Institutions
86Shares Held
24.2MCall Options Held
1.4KPut Options Held
0-
Wynnefield Capital Inc New York, NY4.7MShares$00.0% of portfolio
-
Legion Partners Asset Management, LLC Los Angeles, CA4.43MShares$00.0% of portfolio
-
Greenhaven Road Investment Management, L.P. Greenwich, CT3.62MShares$00.0% of portfolio
-
325 Capital LLC New York, NY2.16MShares$00.0% of portfolio
-
22 Nw, LP Seattle, WA1.76MShares$00.0% of portfolio
About LANDEC CORP \CA\
- Ticker LNDC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 29,595,600
- Description
- Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...